Clinical Trial Update: Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design [Phase 4]

View source ↗

Summary

Phase 4 study update assessing pharmacokinetic equivalence between generic and brand-name antiepileptic drugs in people with epilepsy using a chronic-dose, four…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Antiepileptic drug (generic vs brand)

Snippet

Sponsor: University of Cincinnati | Conditions: Epilepsy | Phase 4 | Status: COMPLETED